MesotheliomaPhase 1NCT06885697
TNhYP218 CAR T Cells
Anti-Mesothelin TNaive/SCM hYP218 (TNhYP218) CAR T Cells in Participants With Mesothelin-Expressing Solid Tumors Including Mesothelioma
CD40L-Augmented TIL for Patients With EGFR, ALK, ROS1 or HER2-Driven NSCLC
What the film says
Some lung cancers are driven by one broken gene: EGFR, ALK, ROS1, or HER2. Targeted pills work, for a while. When they stop, immunotherapy rarely helps.
The idea: the few immune cells that did find the tumor are the right ones. Grow them into an army.
Surgeons remove a piece of tumor. In the lab, the T cells inside it are pulled out, sharpened with a signal called CD40 ligand, and multiplied into billions. After chemotherapy clears space, they return by infusion, with nivolumab to keep them switched on.
In Moffitt's earlier lung trial, tumors shrank in eleven of thirteen patients. This trial, led by Ben Creelan, asks whether it is safe in gene-driven cancers. Public record; not medical advice.
Sources behind this film
Driven by EGFR, ALK, ROS1, or HER2; targeted pills then progression; Tumor piece removed, TIL grown out with CD40L, expanded, given after lymphodepletion with IL-2 and nivolumab; Led by Ben Creelan
Gainor JF. Clin Cancer Res, 2016
Immunotherapy rarely helps; few changes immune cells recognize
Mazieres J. Ann Oncol, 2019
Immunotherapy rarely helps; few changes immune cells recognize
Creelan BC. Nat Med, 2021
Earlier lung trial: tumors shrank in 11 of 13 evaluable; two complete responses ongoing 1.5 years
The drug
Tumor harvest for TIL growth in the lab: A sample of the participant's tumor will be collected and sent to the lab for TIL growth. TIL will be prepared and cryopreserved.
On day 0, all patients will receive a dose infusion TIL cells.
The study
To determine the effect of a special preparation of cells, called tumor-infiltrating lymphocytes (TIL) stimulated with CD40L, when given with the drug nivolumab, for patients with EGFR, ALK, ROS1, or HER2-genomically altered lung cancer.
Eligibility
Inclusion criteria as written on the registry, trimmed. The full list, with exclusions, is on the live record.
For you, or someone you love
A complex diagnosis brings new questions every week, in a trial and out of one. Triangle keeps your whole medical file together, reads it with you in plain language, and helps you and your family decide what to ask next.
Then $9 a month. Cancel anytime.
Requested from your hospitals and clinics through the national networks. Add scans, pathology and anything on paper.
Reports explained as they come in, with lab values you can follow before treatment, during a trial and after.
Ask about your own file, and walk in with questions for your oncologist or the trial team.
Share one profile with the family helping you, and with your doctors.
Members also get a deeper analysis of their records and any sequencing data, including clinical trials that may fit, reviewed by a licensed physician before they receive it.
It turns into a project to manage: visits, scans, labs, side effects and paperwork. Triangle keeps it organized in one place for you or for whoever's helping.
Organize my trial7-day free trial, then $9 a month. Cancel anytime.
How these trials work: what Phase 1 actually is · common questions Not clinical evidence.